Tuberculosis is a public health problem worldwide, including in the United States—
particularly among immunocompromised patients and other high-risk groups. Tuberculosis …

In patients with HIV-1 infection who are starting combination antiretroviral therapy (ART), the
incidence of immune reconstitution inflammatory syndrome (IRIS) is not well defined. We did …

Tuberculosis (TB) and human immunodeficiency virus/acquired immunodeficiency
syndrome (HIV/AIDS) constitute the main burden of infectious disease in resource-limited …

Background Raltegravir (MK-0518) is an inhibitor of human immunodeficiency virus type 1
(HIV-1) integrase active against HIV-1 susceptible or resistant to older antiretroviral drugs …

Background The continuing, randomised, multinational, phase IIB POWER 1 and 2 studies
aim to evaluate efficacy and safety of darunavir in combination with low-dose ritonavir in …

Cryptococcal immune reconstitution inflammatory syndrome (IRIS) may present as a clinical
worsening or new presentation of cryptococcal disease after initiation of antiretroviral …

This report updates and combines into one document earlier versions of guidelines for
preventing and treating opportunistic infections (OIs) among HIV-exposed and HIV-infected …

The immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients initiating
antiretroviral therapy (ART) results from restored immunity to specific infectious or non …

Objective: To determine the incidence, clinical manifestations, risk factors and outcome of
immune reconstitution inflammatory syndrome (IRIS) in South Africa. Design: Prospective …

While the incidence of cryptococccal meningitis in the developed world has declined with
widespread, early antiretroviral therapy (ART), cryptococcal disease remains a major …